167 related articles for article (PubMed ID: 19361150)
1. Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism.
Klinge R; Djøseland O; Karlberg BE; Hall C
Clin Physiol; 1997 Jul; 17(4):389-400. PubMed ID: 19361150
[TBL] [Abstract][Full Text] [Related]
2. An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.
Klinge R; Hystad M; Kjekshus J; Karlberg BE; Djøseland O; Aakvaag A; Hall C
Scand J Clin Lab Invest; 1998 Dec; 58(8):683-91. PubMed ID: 10088206
[TBL] [Abstract][Full Text] [Related]
3. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin II receptor blockade on N-terminal proatrial natriuretic factor plasma levels in chronic heart failure.
Klinge R; Polis A; Dickstein K; Hall C
J Card Fail; 1997 Jun; 3(2):75-81. PubMed ID: 9220306
[TBL] [Abstract][Full Text] [Related]
5. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
[TBL] [Abstract][Full Text] [Related]
7. Measurement and significance of circulating natriuretic peptides in cardiovascular disease.
Sagnella GA
Clin Sci (Lond); 1998 Nov; 95(5):519-29. PubMed ID: 9791037
[TBL] [Abstract][Full Text] [Related]
8. Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Clin Sci (Lond); 2004 Jun; 106(6):569-76. PubMed ID: 14723602
[TBL] [Abstract][Full Text] [Related]
9. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis.
Ogawa T; Veinot JP; Kuroski de Bold ML; Georgalis T; de Bold AJ
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2596-603. PubMed ID: 18408131
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
[TBL] [Abstract][Full Text] [Related]
13. Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure.
Dickstein K; Aarsland T; Hall C
J Card Fail; 1997 Jun; 3(2):83-9. PubMed ID: 9220307
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
J Am Coll Cardiol; 2000 Mar; 35(3):714-21. PubMed ID: 10716475
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
Leskinen H; Vuolteenaho O; Ruskoaho H
Circ Res; 1997 Jan; 80(1):114-23. PubMed ID: 8978330
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
[TBL] [Abstract][Full Text] [Related]
17. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
Hall C; Rouleau JL; Moyè L; de Champlain J; Bichet D; Klein M; Sussex B; Packer M; Rouleau J; Arnold MO
Circulation; 1994 May; 89(5):1934-42. PubMed ID: 8181115
[TBL] [Abstract][Full Text] [Related]
18. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
[TBL] [Abstract][Full Text] [Related]
19. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
Loke I; Squire IB; Davies JE; Ng LL
Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease.
Mathisen P; Hall C; Simonsen S
Scand J Clin Lab Invest; 1993 Feb; 53(1):41-9. PubMed ID: 8451600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
